Nrx Pharma Seeks Us Fda Breakthrough Therapy Status For Zyesami In Patients At Immediate Risk Of Death From Covid-19 Despite Treatment With Remdesivir And Other Approved Therapies
Nrx Pharmaceuticals Announced Today That It Has Filed A New Breakthrough Therapy Designation (Btd) Request With The Us Food And Drug Administration (Fda) Focused On Patients With Critical Covid-19 And Respiratory Failure Who Are At Immediate Risk Of Death Despite Treatment With Remdesivir And Other Approved Therapies.Nrx Filed The Request After The Fda
Optimize Your trial insights with Clival Database.
Are you exhausted from the uncertainty of trial insights pricing? Clival Database ensures the clarity in the midst of the global scenario for clinical trials to you.Clival Database is one of the best databases that offers an outstanding number of clinical trial data in terms of 50,000+ molecules and from primary regulatory markets as well as new entrants like Indian and Chinese markets.
With Clival, you get accurate positioning of historical sales data, patent database, company profiling, safety & efficacy, and prediction of launch of new innovative molecules helping you to align your research and driving down the cost.
To add value, we further break down our analytics for you so that improving your operational effectiveness; optimizing your clinical trials; and offering you accurate and high-quality data at lowest possible prices becomes possible.
Elevate your trial success rate with the cutting-edge insights from Clival database.
Check it out today and make more informed sourcing decisions! Learn More!
